openPR Logo
Press release

Myopia Pipeline 2024 | Sydnexis, Sunhawk Vision Biotech, Vyluma, Eyenovia, Cloudbreak Therapeutics, Stuart Therapeutics

08-05-2024 08:52 PM CET | Health & Medicine

Press release from: ABNewswire

Myopia Pipeline 2024 | Sydnexis, Sunhawk Vision Biotech,

DelveInsight's, "Myopia Pipeline Insight 2024" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Myopia pipeline landscape. It covers the Myopia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myopia therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Discover the latest drugs and treatment options in the Myopia Pipeline. Dive into DelveInsight's comprehensive report today! @ Myopia Pipeline Outlook [https://www.delveinsight.com/sample-request/myopia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Key Takeaways from the Myopia Pipeline Report

* July 2024:- Hoffmann-La Roche - This is a Phase III, multicenter, randomized, double-masked, active comparator-controlled study evaluating the efficacy and safety of faricimab in patients with myopic choroidal neovascularization (CNV). This non-inferiority study will compare 6.0 mg faricimab versus 0.5 mg ranibizumab administered at a pro-re-nata (PRN) dosing regimen after an initial active IVT treatment administration at randomization (Day 1).
* July 2024:- VIS Inc. - The goal of this clinical trial is to evaluate the safety and efficacy of using the VIS Opti-K System to enable monovision by providing temporary improvement in near vision through the treatment of the non-dominant eye of low myopic, emmetropic and low hyperopic presbyope subjects. The main questions it aims to answer are determining uncorrected near visual acuity at 40cm in the treated eye and subjective improvement as measured by the patient satisfaction questionnaire.
* DelveInsight's Myopia pipeline report depicts a robust space with 8+ active players working to develop 10+ pipeline therapies for Myopia treatment.
* The leading Myopia Companies such as Sydnexis, Sunhawk Vision Biotech, Vyluma, Eyenovia, Cloudbreak Therapeutics, Stuart Therapeutics , and others.
* Promising Myopia Therapies such as SYD-101 Dose 1, Alleance, NVK-002 Concentration 1, QLM3004 Concentration 1, Atropine Sulfate 01, and others.

Stay ahead with the most recent pipeline outlook for Myopia. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Myopia Treatment Drugs [https://www.delveinsight.com/sample-request/myopia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Myopia Emerging Drugs Profile

* Atropine micro-formulation (MicroPine): Eyenovia

MicroPine is a proprietary microdose formulation of atropine used in our Optejet dispenser and product candidate for the prevention of progressive myopia (nearsightedness) in children. It is believed that Eyenovia's delivery technology is particularly well-suited for this application and patient population, potentially enabling children to easily self-administer atropine medication while minimizing dose-related side effects. Currently, the drug is in Phase III stage of its clinical trial for the treatment of Myopia.

* SYD-101: Sydnexis

SYD-101 is an investigational low-dose atropine sulfate ophthalmic solution, 0.01% and 0.03%, designed to achieve efficacy, stability, and reduce discomfort for improved treatment continuity, according to studies on the treatment of childhood myopia. While published reports have shown low concentrations of compounded atropine to be effective, these solutions are limited by short shelf life and remain only stable if markedly acidified, which can also cause excessive burning and stinging in children, according to several studies on atropine for myopia. Currently, the drug is in phase III stage of its clinical trial for the treatment of Myopia.

Explore groundbreaking therapies and clinical trials in the Myopia Pipeline. Access DelveInsight's detailed report now! @ New Myopia Drugs [https://www.delveinsight.com/sample-request/myopia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Myopia pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration

* Intra-articular
* Intraocular
* Intrathecal
* Intravenous
* Ophthalmic
* Oral
* Parenteral
* Subcutaneous
* Topical
* Transdermal

Myopia Products have been categorized under various Molecule types such as

* Oligonucleotide
* Peptide
* Small molecule

Unveil the future of Myopia Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight's expert analysis @ Myopia Market Drivers and Barriers [https://www.delveinsight.com/sample-request/myopia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Scope of the Myopia Pipeline Report

* Coverage- Global
* Myopia Companies- Sydnexis, Sunhawk Vision Biotech, Vyluma, Eyenovia, Cloudbreak Therapeutics, Stuart Therapeutics, and others.
* Myopia Therapies- SYD-101 Dose 1, Alleance, NVK-002 Concentration 1, QLM3004 Concentration 1, Atropine Sulfate 01, and others.
* Myopia Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
* Myopia Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Get the latest on Myopia Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ Myopia Companies, Key Products and Unmet Needs [https://www.delveinsight.com/sample-request/myopia-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Table of Content

* Introduction
* Executive Summary
* Myopia: Overview
* Pipeline Therapeutics
* Therapeutic Assessment
* Myopia - DelveInsight's Analytical Perspective
* Late Stage Products (Phase III)
* Atropine micro-formulation (MicroPine): Eyenovia
* Drug profiles in the detailed report.....
* Mid Stage Products (Phase II)
* Drug Name: Company Name
* Drug profiles in the detailed report.....
* Early Stage Products (Phase I)
* Drug Name: Company Name
* Drug profiles in the detailed report.....
* Preclinical Stage Products
* Drug Name: Company Name
* Drug profiles in the detailed report.....
* Inactive Products
* Myopia - Collaborations Assessment- Licensing / Partnering / Funding
* Myopia - Unmet Needs
* Myopia - Market Drivers and Barriers
* Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=myopia-pipeline-2024-sydnexis-sunhawk-vision-biotech-vyluma-eyenovia-cloudbreak-therapeutics-stuart-therapeutics]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Myopia Pipeline 2024 | Sydnexis, Sunhawk Vision Biotech, Vyluma, Eyenovia, Cloudbreak Therapeutics, Stuart Therapeutics here

News-ID: 3611312 • Views:

More Releases from ABNewswire

Edge AI Software Market Leading Companies, Recent Trends, Growth Outlook, Future Scope and Demand to 2031
Edge AI Software Market Leading Companies, Recent Trends, Growth Outlook, Future …
Edge AI Software Market by Offering (Platform, Frameworks & Toolkits), Technology (Generative AI, Machine Learning, NLP, Computer Vision), Data Modality (Spatial Data, Temporal Data, Visual Data, Multimodal Data, Textual Data) - Global Forecast to 2031. The Edge AI Software Market [https://www.marketsandmarkets.com/Market-Reports/edge-ai-software-market-70030817.html?utm_campaign=edgeaisoftwaremarket&utm_source=abnewswire.com&utm_medium=referral] is expected to grow at a compound annual growth rate (CAGR) of 24.4% between 2025 and 2031, from an estimated USD 2.40 billion in 2025 to USD 8.88 billion by
ANJ Appliances & Outdoor Living Emerges as Premier Destination for Luxury Outdoor Kitchen Solutions
ANJ Appliances & Outdoor Living Emerges as Premier Destination for Luxury Outdoo …
ANJ Appliances & Outdoor Living has quickly established itself as a trusted source for premium outdoor kitchen brands, partnering with over 15 leading manufacturers including TrueFlame, Twin Eagles, and Fire Magic. The company's commitment to quality, transparency, and customer service is driving rapid national expansion as affluent homeowners increasingly invest in elevated outdoor living spaces. The outdoor living industry is experiencing unprecedented growth as homeowners reimagine their properties as extensions of
ShadowworksCrafts Illuminates Home Decor Market with Innovative Push-Button Wall Art Creations
ShadowworksCrafts Illuminates Home Decor Market with Innovative Push-Button Wall …
ShadowworksCrafts introduces a unique approach to home decor with illuminated push-button wall art that combines artistic design with interactive functionality. The company offers both original designs and custom creations, providing homeowners with personalized lighting solutions that serve as both conversation pieces and functional accent lighting. ShadowworksCrafts has emerged as an innovative force in the home decor industry with its distinctive illuminated push-button wall art that transforms traditional decorative pieces into interactive
At Just 13, Kaylee Johnson Turns Pain Into Purpose With Her Debut Book When Silence Speaks, Releasing October 31
At Just 13, Kaylee Johnson Turns Pain Into Purpose With Her Debut Book When Sile …
When Silence Speaks: Where Addiction Lives, Children Suffer in Silence by 13-year-old author Kaylee J. releases Oct. 31. Through honest storytelling, she sheds light on how addiction affects children in real time-emotionally, mentally, and spiritually-urging adults to recognize the impact, listen with compassion, and begin the conversations that lead to healing. This October, during National Substance Abuse Prevention Month and National Youth Substance Use Prevention Month, a brave young voice is

All 5 Releases


More Releases for Myopia

Myopia Market Assessment & Forecast: Strategic Insights into Pediatric Myopia Ma …
Albany, United States - September 25, 2025 - DelveInsight, a leading provider of market intelligence and strategic consulting services in the healthcare sector, has released a comprehensive case study report on Myopia Market Assessment & Forecast, providing in-depth insights into the pediatric myopia landscape across Asia. This detailed study highlights prevalence trends, treatment paradigms, and market opportunities, equipping stakeholders with the actionable intelligence required to make informed decisions in the
Myopia Control Lenses Market Forecast to Expand at 16.2% CAGR Amid Increasing Pe …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Myopia Control Lenses Market- (By Lens Type (Multifocal Lenses, Orthokeratology Lenses, Dual-Focus Lenses, Peripheral Defocus Lenses), By Age Group (Children, Adults), By Distribution Channel (Optometry Clinics, Optical Retail Stores, Online Retail)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic, the Global Myopia Control Lenses Market is valued
Latest Trends In Myopia Treatment Devices Market
A cutting-edge solution to the problem of myopia or nearsightedness is a wearable gadget for myopia control. These tools, which frequently come in the shape of smart glasses or specialised contact lenses, make use of cutting-edge technology to control and slow the growth of myopia. Wearable myopia control devices offer a proactive method of maintaining eye health by utilising features like changeable focus, customised vision correction, and real-time monitoring. Request
Myopia Control Devices Market - Seeing Beyond Blur: Revolutionary Myopia Devices …
Newark, New Castle, USA: The "Myopia Control Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Myopia Control Devices Market: https://www.growthplusreports.com/report/myopia-control-devices-market/7989 This latest report researches the industry structure,
Myopia Control Devices Market - Unlocking the Future of Clear Sight: Myopia Cont …
Newark, New Castle, USA - new report, titled Myopia Control Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Myopia Control Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Myopia Control Devices market. The report offers an overview of
The Myopia Market is expected to be driven by the factors such as the rising cas …
The Myopia market is expected to show positive growth, mainly attributed to the increased diagnosed prevalence and also, the launch of upcoming devices during the forecast period. Moreover, advances in disease mechanisms have yielded new diagnostic and treatment approaches, opening avenues to better treatment interventions. The Myopia market report provides current treatment practices, emerging drugs, Myopia market share of the individual therapies, current and forecasted Myopia market Size from 2019 to